Latest Share Chat

IN BRIEF: NetScientific's ProAxsis Partners Up With DiaPharma

Thu, 19th Nov 2020 20:21

NetScientific PLC - life sciences and technology investment and commercialisation company - Says portfolio company ProAxsis Ltd appoints DiaPharma Group Inc as exclusive distributor of its portfolio of respiratory research assays for key North America region. Partnership agreement provides DiaPharma exclusive access to ProAxsis' activity-based immunoassay kits for the quantification of the active forms of neutrophil elastase, proteinase 3 and cathepsin G.

Current stock price: 58.10 pence

Year-to-date change: down 14%

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Related Shares

More News

15 Apr 2024 11:06

NetScientific investee secures funding to develop product range

(Alliance News) - NetScientific PLC on Monday said its portfolio company ProAxsis Ltd secured GBP1.8 million in investment.

27 Mar 2024 18:47

TRADING UPDATES: Empire Metals targets key milestones in Australia

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

13 Mar 2024 17:04

NetScientific "significantly" advances strategic goals

(Alliance News) - NetScientific PLC on Wednesday released a portfolio and strategy update.

23 Jan 2024 18:39

TRADING UPDATES: Esken's Southend Airport faces further allegations

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

1 Dec 2023 11:59

IN BRIEF: NetScientific investee DeepTech Recycling bags GBP1 million

NetScientific PLC - technology and life sciences investor - Portfolio company DeepTech Recycling Ltd closes GBP1 million fundraising. DeepTech, in whi...